Welltok Leverages Predictive Models to Increase Medication Adherence by Up to 85%

DENVER, March 3, 2020 /PRNewswire/ — Most consumers are medication non-compliant according to the American Medical Association – either never filling a prescription or not taking medication as instructed. And, with the increase in chronic conditions and an aging population, the number of medications to be filled and adhered to are on the rise. By proactively identifying and breaking down potential barriers, Welltok is helping to increase adherence and refill rates by up to 85% with a personalized and multi-channel approach.

Welltok works with the industry’s leading health plans, pharmacy benefit managers (PBMs), retail and specialty pharmacies to conduct successful medication adherence programs. Welltok starts by combining client’s clinical data and its proprietary consumer database, including social determinants of health, to predict individuals at risk of non-compliance or those most likely to refill with a reminder. The company then conducts targeted outreach through the communication channel(s) they will be most receptive to like email, text and automated voice to drive the targeted actions.

“Medication adherence continues to be a costly challenge for the industry that’s directly dependent on consumers taking action,” said April Gill, senior vice president of market solutions for Welltok. “We’ve found that people’s barriers can typically be addressed with highly automated features like a digital reminder or a mail order option that delivers high returns. By predicting key behaviors such as who will be non-adherent or more likely to use generics, we can create personalized, early interventions that not only save lives, but create business value and reduce operational costs for our clients.”

Welltok runs thousands of predictive models to identify potential barriers, individual risks and needs, and member receptivity to interventions. For example, insights revealed that registered voters are more adherent to their medications and treatment plans than non-voters. And, seniors who reside in areas with a high percentage of widowed people are more likely to be impacted and improve adherence after intervention.

Welltok’s Pharmacy Solution conducts targeted, multi-channel campaigns based on sponsor objectives including:

  • Medication Adherence: identify barriers and deliver barrier-breaking messages and execute Medicare Advantage Stars and Medication Therapy Management (MTM) initiatives
  • Automated Reminders: general reminders, education with refill prompts and transfer to live agents when additional support is needed
  • Formulary Programs: formulary changes, prior authorization and consent for fulfillment
  • Operational Efficiency Programs: order and shipping status/confirmation and account past due
  • Savings Programs: automatic refill/renewal programs, preferred pharmacy, retail-to-mail and 30-90-day programs

Learn more and see real results from medication adherence campaigns by registering here for a solution webinar on March 17 at 1pm ET.

ABOUT WELLTOK
Welltok is a consumer activation company that drives individuals to take actions that optimize their total wellbeing. Only Welltok leverages advanced analytics and machine learning to engage consumers with timely and relevant multi-channel, personalized resources and incentives. Our solutions integrate data driven SaaS software, curated resources and professional services to help health plans, employers, providers and public entities drive growth, build longitudinal relationships and improve healthcare value. Follow us on Twitter @Welltok.

Media Contact
Erica Sniad Morgenstern
415.697.3496
pr@welltok.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/welltok-leverages-predictive-models-to-increase-medication-adherence-by-up-to-85-301015519.html

SOURCE Welltok, Inc.

Staff

Recent Posts

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite"…

1 hour ago

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

'Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co.,…

8 hours ago

Casect Launches AI-Enhanced Case Log Platform for Surgeons

SHERIDAN, Wyo., Dec 25, 2024 /PRNewswire/ -- Casect, LLC, a medical education technology company, announces…

14 hours ago

CorVel Announces Effectiveness of Three-For-One Forward Stock Split

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced…

23 hours ago

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be…

23 hours ago